Form EFFECT Anebulo Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 23, 2025 |
| Accession Number: | 0001493152-25-014238 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calfrac Reports Second Quarter 2026 Results
- Bloom Energy Continues to Set the Standard for AI Onsite Power with Expanded MiTAC Partnership
- Ucore Announces $60 Million Bought Deal Public Offering of Common Shares
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
